Anticoagulant prophylaxis for placenta mediated pregnancy complications

Thrombosis Research

Volumn 127, Issue SUPPL. 3, 2011, Pages

  Rodger, Marc A ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Anticoagulant prophylaxis; Placenta; Pregnancy complications

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 5 LEIDEN; DALTEPARIN; DIPEPTIDYL CARBOXYPEPTIDASE; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PROTHROMBIN;

ANTICOAGULANT THERAPY; ARTICLE; CHEMOPROPHYLAXIS; DISEASE ASSOCIATION; EMBOLISM PREVENTION; FETUS WASTAGE; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; SMALL FOR DATE INFANT; SOLUTIO PLACENTAE; SYSTEMATIC REVIEW; THROMBOPHILIA;

ANTICOAGULANTS; FEMALE; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; THROMBOPHILIA;

EID: 79251477872     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(11)70021-4     Document Type: Article

References (33)

1. B Brenner Thrombophilia and adverse pregnancy outcome Obstetrics & Gynecol Clin North Am 33 3 2006 443 456 ix.
2. MA Rodger, M Paidas, C McLintock, S Middeldorp, S Kahn, I Martinelli Inherited thrombophilia and pregnancy complications revisited Obstet Gynecol 112 2 Pt 1 2008 320 324
3. JL Kujovich Thrombophilia and pregnancy complications Am J Obstet Gynecol 191 2004 412 424
4. K Brown, R Luddington, D Williamson, P Baker, T Baglin Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3′-untranslated region of the prothrombin gene Br J Haematol 98 1997 907 909
5. T Koster, AD Blann, E Briet, JP Vandenbroucke, FR Rosendaal Role of clotting factor VIII in effect of von Willebrand factor on occurrence of DVT Lancet 345 1995 152 155
6. RA Kraaijenhagen, PS Anker, MMW Koopman, PH Reitsma, MH Prins, A van den Ende High plasma concentration of Factor VIIIc is a major risk factor for venous thromboembolism Thromb Haemost 83 1 2000 5 9
7. SR Poort, FR Rosendaal, PH Reitsma, RM Bertina A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis Blood 88 1996 3698 3703
8. F Rodeghiero, A Tosetto The epidemiology of inherited thrombophilia: the VITA Project. Vicenza Thrombophilia and Atherosclerosis Project Thromb Haemost 78 1 1997 636 640
9. JC Souto, I Coll, D Llobet, E del Rio, A Oliver, J Mateo The prothrombin 20210A allele is the most prevalent genetic risk factor for venous thromboembolism in the Spanish population Thromb Haemost 80 1998 366 369
10. FJ van der Meer, T Koster, JP Vandenbroucke, E Briet, FR Rosendaal The Leiden Thrombophilia Study (LETS) Thromb Haemost 78 1997 631 635
11. B Isermann, R Sood, R Pawlinski, M Zogg, S Kalloway, JL Degen The thrombomodulin-protein C system is essential for the maintenance of pregnancy Nat Med 9 3 2003 331 337
12. O Wu, L Robertson, S Twaddle, GD Lowe, P Clark, M Greaves Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study Health Technol Assess 10 2006 1 110
13. EF Funai Inherited thrombophilia and preeclampsia: is the evidence beginning to congeal? [comment] Am J Obstet Gynecol 2 2009 121 122
14. MA Rodger, MT Betancourt, P Clark, PG Lindqvist, D Dizon-Townson, J Said The association of factor V Leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies PLoS Med 7 6 2010 :e1000292
15. ME Helewa, RF Burrows, J Smith, K Williams, P Brain, SW Rabkin Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy CMAJ 157 1997 715 725
16. BM Schroeder, American College of Obstetricians and Gynecologists ACOG practice bulletin on diagnosing and managing preeclampsia and eclampsia. American College of Obstetricians and Gynecologists Am Family Physician 66 2 2002 330 331
17. M Karakantza, G Androutsopoulos, A Mougiou, G Sakellaropoulos, G Kourounis, G Decavalas Inheritance and perinatal consequences of inherited thrombophilia in Greece Int J Gynaecol Obstet 100 2 2008 124 129
18. G Mello, E Parretti, C Fatini, C Riviello, F Gensini, M Marchionni Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women Hypertension 45 1 2005 86 91
19. PS Wells, MA Rodger, MA Forgie, NJ Langlois, L Armstrong, N Carson The ACE D/D genotype is protective against the development of idiopathic deep vein thrombosis and pulmonary embolism Thromb Haemost 90 2003 829 834
20. E Rey, P Garneau, M David, R Gauthier, L Leduc, N Michon Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial J Thromb Haemost 7 2009 58 64
21. RS Strauss Adult functional outcome of those born small for gestational age: twenty-six-year follow-up of the 1970 British Birth Cohort JAMA 283 2000 625 632
22. HE Howley, M Walker, MA Rodger A systematic review of the association between factor V Leiden or prothrombin gene variant and intrauterine growth restriction Am J Obstet Gynecol 192 2005 694 708
23. Anderson MS, Hay WW. Intrauterine growth restriction and the small-for-gestational-age infant. In: MacDonald MG, Seshia MM, Mullet MD, editors, Avery's Neonatology. 2005.
24. HL Galan, JC Hobbins Intrauterine growth restriction JR Scothh RS Gibbs RS Gibbs BY Karlan AF Haney Danforth's Obstetrics & Gynecology 2003 Lippicott Williams & Wilkins 204
25. D Dizon-Townson, C Miller, B Sibai, CY Spong, E Thom, G Wendel Jr The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus Obstet Gynecol 106 3 2005 517 524
26. T Dudding, J Heron, A Thakkinstian, E Nurk, J Golding, M Pembrey Factor V Leiden is associated with pre-eclampsia but not with fetal growth restriction: a genetic association study and meta-analysis J Thromb Haemost 6 2008 1869 1875
27. PG Lindqvist, P Svensson, B Dahlback Activated protein C resistance in the absence of factor V Leiden and pregnancy J Thromb Haemost 42 2006 361 366
28. RP Murphy, C Donoghue, RJ Nallen, M D'Mello, C Regan, AS Whitehead Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylenetetrahydrofolate reductase polymorphisms in pregnancy Arterioscler Thromb Vasc Biol 20 2000 266 270
29. MA Rodger, MC Walker, S Wu Wen, G Smith, N Carson, B Gin Factor V Leiden (FVL) and prothrombin gene variant (PGV) may be only weakly associated with placenta mediated pregnancy complications: A large prospective cohort study J Thromb Haemost 5 Suppl 2 2007 (Abstract).
30. JM Said, JR Higgins, EK Moses, SP Walker, AJ Borg, PT Monagle Inherited thrombophilia polymorphisms and pregnancy outcomes in nulliparous women Obstet Gynecol 115 1 2010 5 13
31. O Salomon, U Seligsohn, DM Steinberg, Y Zalel, A Lerner, N Rosenberg The common prothrombotic factors in nulliparous women do not compromise blood flow in the feto-maternal circulation and are not associated with preeclampsia or intrauterine growth restriction Am J Obstet Gynecol 191 2004 2002 2009
32. P Clark, ID Walker, L Govan, O Wu, IA Greer The GOAL study: a prospective examination of the impact of factor V Leiden and ABO(H) blood groups on haemorrhagic and thrombotic pregnancy outcomes Br J Haematol 140 2008 236 240
33. JC Gris, C Chauleur, JL Faillie, G Baer, P Mares, P Fabbro-Peray Enoxaparin for the secondary prevention of placental vascular complications in women with abruptio placentae. The pilot randomised controlled NOH-AP trial Thromb Haemost 104 4 2010 771 779